MedPath

Walking Program in Fatty Liver Children With Phenylketonuria

Not Applicable
Recruiting
Conditions
Phenylketonurias
Non Alcoholic Fatty Liver
Registration Number
NCT06718842
Lead Sponsor
Cairo University
Brief Summary

phenylketonuria (commonly known as PKU) is an inherited disorder that increases the levels of a substance called phenylalanine in the blood. PKU is usually associated with many metabolic complication including non-alcoholic fatty liver

Detailed Description

this study will include PKU children sufferers 9n=40) with non-alcoholic fatty liver to be randomly assigned to group I (n=20) that will perform walking program (online supervised free walking that will be applied daily for eight weeks) or group II (N=20) that will act as waitlisted children

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
40
Inclusion Criteria
  • PKU children
  • obese children
  • fatty liver children (non-alcoholic fatty liver)
Exclusion Criteria
  • cardiac children
  • diabetic children
  • neurogenic disorders
  • respiratory and renal problems

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
alanine transamianseit will be assessed after eight weeks

it is a serum liver enzyme

Secondary Outcome Measures
NameTimeMethod
aspartate tranaminaseit will be assessed after eight weeks

it is a serum liver enzyme

Gamma-glutamyl Transferaseit will be assessed after eight weeks

it is a serum liver enzyme

alkaline phosphataseit will be assessed after eight weeks

it is a serum liver enzyme

triglyceridesit will be assessed after eight weeks

it will be measured in the serum

body mass indexit will be assessed after eight weeks

it will be measured after emptying bladder

Trial Locations

Locations (1)

Cairo University

🇪🇬

Dokki, Giza, Egypt

© Copyright 2025. All Rights Reserved by MedPath